Search Results

0 results for 'Merck'

You can use to get even better search results
May 22, 2019 | Law.com

Critical Mass: SCOTUS Ruling on "Clear Evidence" Not That Clear? Judge Hands Out More Roundup Sanctions

The U.S. Supreme Court ruled this week on a key question about federal preemption—but the answer wasn't as clear as lawyers had hoped.
5 minute read
May 08, 2019 | Law.com

Critical Mass: MDL Litigation Funding Arrangements Placed Under Microscope. Plus: Did Jurors Sway Judge in RoundUp Trial?

With no federal statute or guideline, judges are taking the initiative to find out about third-party funding of mass-tort litigation
5 minute read
March 13, 2019 | Law.com

Critical Mass: Congress Eyes FDA Regulation of Talc Products. Plus, SF Jury Mulls Case Over Weedkiller

Johnson & Johnson executives did not appear before the subcommittee looking into the alleged link between talc products and cancer, but the company was an obvious focus of the hearing
4 minute read
March 07, 2019 | New Jersey Law Journal

Judge Rejects Plaintiff Firms' Demand for More Fees in Merck Securities MDL

The Whitehead Law Firm of Lafayette, Louisiana, and Goforth Lewis & Sanford of Houston claimed they had a fee-sharing deal with New York's Stull, Stull & Brody when the firms teamed up on securities litigation against Merck & Co.
4 minute read
January 22, 2019 | The Legal Intelligencer

Inventive Claims May Be Unconstitutional in Products Liability Cases

Products liability litigation has become more sophisticated during the 21st century as products themselves have become more complex, interconnected and regulated.
9 minute read
January 11, 2019 | Property Casualty 360

New world of cyberattacks: $100 million lawsuit against Zurich

The legal action asserts that Zurich's application of the exclusion to a cyberattack was unprecedented.
5 minute read
January 09, 2019 | Law.com

Critical Mass: SCOTUS Looks at Preemption in Drug Labeling Case. Plus, Fee Dispute Roils Hip Implant MDL

In oral arguments Monday, Merck made its case for federal preemption before the U.S. Supreme Court, saying there was "clear evidence" that the FDA would have rejected language in a warning label proposed for its osteoporosis drug Fosamax.
4 minute read
December 20, 2018 | Litigation Daily

Litigators of the Week for 2018, Take a Bow

From challenging efforts to un-do the Deferred Action for Childhood Arrivals program to prosecuting Bill Cosby to rebuffing DOJ's bid to block the merger of AT&T and Time Warner, here's the full list of our Litigators of the Week this year.
15 minute read
November 09, 2018 | New Jersey Law Journal

Accutane Decisions Are Settling Important Questions

Taken together, the decisions represent an established philosophy that will shape the outcomes of significant litigation in New Jersey for years to come.
8 minute read
October 19, 2018 | Litigation Daily

Litigators of the Week: The Weil Team that Turned the Tide for J&J

'From the very start of the case, we hit hard on our theme that this case was a fraud perpetrated by plaintiffs' lawyers for money.'
8 minute read

TRENDING STORIES

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now